We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Robert Lundie-Smith McDermott Will & Emery

Results 1 to 3 of 3



UK Supreme Court steps into line with Europe, but rejects U.S. approach *

European Union, United Kingdom, USA - November 30 2011
The UK’s highest court recently considered the provisions of the European Patent Convention (EPC) centering on the “susceptible of industrial application” requirement in the context of a patent describing a DNA sequence for a new protein, Neutrokine-α, which was a member of a group of similar proteins known as the TNF ligand superfamily.

Co-authors: Hiroshi Sheraton.


SPCs: is a simplistic system becoming too complicated? *

European Union - November 22 2010
Obtaining and enforcing Supplementary Protection Certificates (SPCs) for medicinal products in the European Union is a fertile ground for challenge and the law is still unclear in a number of key areas.

Co-authors: Hiroshi Sheraton.


“Obvious to try”— U.S. and UK positions converge *

United Kingdom, USA - July 27 2009
Post KSR, KSR International Co. v. Teleflex Inc., (see IP Update, Vol. 10, No. 5), the “obvious to try” test has become a hot topic for U.S. patent lawyers.

Co-authors: Gary Moss.